US Edition
Published • loading... • Updated
The risks of direct-to-consumer pharmaceutical advertising and Big Pharma
Summary by KevinMD.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The risks of direct-to-consumer pharmaceutical advertising and Big Pharma
In 2002, prescribing risperidone meant fighting through layers of resistance. I had to argue with formulary doctors, armed with a special copy of the New England Journal of Medicine article where my own name was highlighted, just to gain permission. That was the level of scrutiny these drugs once demanded. The article itself was not Read more… The risks of direct-to-consumer pharmaceutical advertising and Big Pharma originally appeared in KevinM…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
